UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.63
-0.43 (-3.89%)
At close: Apr 1, 2025, 4:00 PM
11.04
+0.41 (3.89%)
After-hours: Apr 1, 2025, 4:07 PM EDT

UroGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
490449463205213398
Upgrade
Market Cap Growth
-2.93%-2.93%126.06%-3.94%-46.44%-43.13%
Upgrade
Enterprise Value
373318409184105276
Upgrade
Last Close Price
11.0610.6515.008.879.5118.02
Upgrade
PS Ratio
5.254.975.603.184.4433.74
Upgrade
PB Ratio
-55.66-51.05-7.10-2.2925.344.13
Upgrade
P/TBV Ratio
----25.344.13
Upgrade
EV/Sales Ratio
4.133.524.952.852.1823.36
Upgrade
Debt / Equity Ratio
-14.19-14.19-1.54-1.120.180.03
Upgrade
Asset Turnover
0.390.390.530.500.400.07
Upgrade
Inventory Turnover
1.191.191.871.671.52-
Upgrade
Quick Ratio
5.595.594.884.714.515.09
Upgrade
Current Ratio
6.016.015.425.395.115.39
Upgrade
Return on Equity (ROE)
-----211.55%-92.88%
Upgrade
Return on Assets (ROA)
-25.77%-25.77%-26.10%-38.69%-47.72%-46.29%
Upgrade
Return on Capital (ROIC)
-79.15%-79.15%-179.24%-479.55%-105.88%-52.96%
Upgrade
Earnings Yield
-25.89%-28.23%-22.08%-53.60%-51.98%-32.27%
Upgrade
FCF Yield
-19.81%-21.60%-16.54%-42.88%-40.17%-26.90%
Upgrade
Buyback Yield / Dilution
-48.70%-48.70%-26.43%-2.05%-2.60%-6.10%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q